or
forgot password

    • cancer clinical trials in fairfax, VA

    • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    Medical Oncology and Hematology Associates of North Virginia - Fairfax
    Fairfax, Virginia 22031
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    INOVA Fair Oaks Hospital
    Fairfax, Virginia 22033
    Breast Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Kaiser Permanente Medical Center - Fair Oaks
    Fairfax, Virginia 22033
    Breast Cancer
    Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer
    Northern Virginia Oncology Group
    Fairfax, Virginia 22031
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter
    Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer
    Northern Virginia Oncology Group, P.C.
    Fairfax, Virginia 22031
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Kaiser Permanente Medical Center - Fair Oaks
    Fairfax, Virginia 22033
    Endometrial Cancer
    Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse
    Fairfax Northern Virginia Hematology Oncology, P.C. - Fairfax
    Fairfax, Virginia 22031
    Lymphoma
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Kaiser Permanente Medical Center - Fair Oaks
    Fairfax, Virginia 22033
    Lymphoma
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Kaiser Permanente Medical Center - Fair Oaks
    Fairfax, Virginia 22033
    Metastatic Cancer, Prostate Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Kaiser Permanente - Fair Oaks Medical Center
    Fairfax, Virginia 22033
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
    Kaiser Permanente Medical Center - Fair Oaks
    Fairfax, Virginia 22033
    Breast Cancer, Lymphedema, Perioperative/Postoperative Complications
    Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer
    Fairfax-Northern Virginia Hematology Oncology, PC
    Fairfax, Virginia 22031
    Non-small Cell Lung Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Medical Oncology Hematology Associates of Northern Virginia Limited
    Fairfax, Virginia 22031
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Fairfax Northern VA Hem-Onc PC
    Fairfax, Virginia 22031
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Fairfax Northern VA Hem-Onc PC
    Fairfax, Virginia 22031
    Breast Cancer
    Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
    Fairfax Northern VA Hem-Onc PC
    Fairfax, Virginia 22031
    Metastatic Gastric or GEJ Cancer
    LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations
    1200.22.31 Boehringer Ingelheim Investigational Site
    Fairfax, Virginia
    Carcinoma, Non-Small-Cell Lung
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Kaiser Permanente - Fair Oaks Medical Center
    Fairfax, Virginia 22033
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    Fairfax Northern VA Hem-Onc PC
    Fairfax, Virginia 22031
    Androgen-independent Prostate Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Medical Oncology Hematology Associates of Northern Virginia Limited
    Fairfax, Virginia 22031
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
    Children's Regional Outpatients Center SC
    Fairfax, Virginia 22031
    Tuberous Sclerosis, Subependymal Giant Cell Astrocytoma
    Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
    Fairfax-Northern Virginia Hematology-Oncology, P.C.

    Trial Locations
    Fairfax-Northern Virginia Hematology-Oncology, P.C.
    Virginia Cancer Specialist, PC
    Metastatic Pancreatic Cancer
    A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
    Fairfax-Northern Virginia Hematology-Oncology PC

    Trial Locations
    Fairfax-Northern Virginia Hematology-Oncology PC
    Fair Oaks Office
    Fairfax Northern VA Hematology-Oncology PC
    Breast Cancer
    Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
    Virginia Cancer Specialists, PC Dept.ofFairfaxNo.VA (2)
    Fairfax, Virginia 22031
    HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Kaiser Permanente Medical Center - Fair Oaks
    Fairfax, Virginia 22033
    Colorectal Cancer, Precancerous Condition
    Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
    Virginia Cancer Specialists, PC

    Trial Locations
    Virginia Cancer Specialists, PC
    Medical Oncology and Hematology Associates of Northern Virginia
    Virginia Surgery Associates
    Carcinoma, Intraductal, Noninfiltrating, DCIS, Ductal Carcinoma In Situ
    Connect® MM- The Multiple Myeloma Disease Registry
    US Oncology - Fairfax-Northern VA Hem-Onc PC
    Fairfax, Virginia 22031
    Multiple Myeloma
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Medical Oncology and Hematology Associates of North Virginia - Fairfax
    Fairfax, Virginia 22031
    Colorectal Cancer
    Study of PX-866 and Docetaxel in Solid Tumors
    Virginia Cancer Specialists
    Fairfax, Virginia
    Non Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    Virginia Cancer Specialists, PC
    Fairfax, Virginia 22031
    Adenocarcinoma of the Lung
    Phase 1 and 2 Study of PX-866 and Cetuximab
    Virginia Cancer Specialists, PC
    Fairfax, Virginia 22031
    Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Kaiser Permanente - Fair Oaks Medical Center
    Fairfax, Virginia 22033
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
    Virginia Cancer Specialists, PC
    Fairfax, Virginia 22031
    Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell
    Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
    Virginia Cancer Specialists PV
    Fairfax, Virginia 22013
    Multiple Myeloma
    Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
    Virginia Cancer Specialists, PC
    Fairfax, Virginia 22031
    Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, Solid Tumors
    Efficacy and Safety Study of NeuVax(TM)(Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
    Virginia Cancer Specialists
    Fairfax, Virginia
    HER2 Negative Breast Cancer
    Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
    Fairfax Northern Virginia Hematology Oncology Dept.ofFairfax SC
    Fairfax, Virginia 22031
    Metastatic Breast Cancer
    A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
    Virginia Cancer Specialists, PC
    Fairfax, Virginia 22031
    Chronic Lymphocytic Leukemia
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Kaiser Permanente - Fair Oaks Medical Center

    Trial Locations
    Kaiser Permanente - Fair Oaks Medical Center
    Virginia Cancer Specialists-Fairfax
    Breast Cancer
    Afatinib Expanded Access Program
    1200.45.045 Boehringer Ingelheim Investigational Site
    Fairfax, Virginia
    Carcinoma, Non-Small-Cell Lung
    A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
    Virginia Cancer Specialists
    Fairfax, Virginia
    Non-small Cell Lung Cancer(NSCLC)
    Early Diagnosis of Pulmonary Nodules
    Inova Healthcare
    Fairfax, Virginia 22042
    Precancerous Conditions, Carcinoma
    A Phase 2 of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
    Virginia Cancer Specialists, PC
    Fairfax, Virginia 22031
    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma, Indolent Non-Hodgkin's Lymphoma
    Oral Rigosertib for Squamous Cell Carinoma
    Virginia Cancer Specialists, PC
    Fairfax, Virginia 22031
    Head and Neck Squamous Cell Carcinoma, Anal Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma
    Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
    Northern Virginia Oncology Group
    Fairfax, Virginia 22031
    Pancreatic Cancer
    Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer
    Northern Virginia Oncology Group, P.C.
    Fairfax, Virginia 22031
    Breast Cancer
    Genetic Study of Young Patients With Colorectal Cancer
    INOVA Fair Oaks Hospital
    Fairfax, Virginia 22033
    Colorectal Cancer
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    Northern Virginia Oncology Group
    Fairfax, Virginia 22031
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms